METTL3 and colorectal cancer: Shen et al. found that METTL3 stabilizes the expressions of HK2 and SLC2A1 (GLUT1) in colorectal cancer through an m6A-IGF2BP2/3-dependent mechanism, further activated the glycolysis pathway [40].